High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression.
Kazuto TsukitaHaruhi Sakamaki-TsukitaSergio KaiserLuqing ZhangMirko MessaPablo Serrano-FernandezRyosuke TakahashiPublished in: Neurology (2023)
This study provides Class II evidence that the CSF proteome contains clinically important information regarding the development and progression of Parkinson disease that can be deciphered by a combination of high-throughput proteomics and machine learning.